Zotefoams (ZTF) Competitors GBX 353 +3.00 (+0.86%) (As of 12/6/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades ZTF vs. ESNT, SCPA, SYNT, TET, IOF, WCH, ITX, DCTA, HDD, and BIOMShould you be buying Zotefoams stock or one of its competitors? The main competitors of Zotefoams include Essentra (ESNT), Scapa Group (SCPA), Synthomer (SYNT), Treatt (TET), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), and Biome Technologies (BIOM). These companies are all part of the "specialty chemicals" industry. Zotefoams vs. Essentra Scapa Group Synthomer Treatt Iofina Wilmcote Holdings plc (WCH.L) Itaconix Directa Plus Hardide Biome Technologies Zotefoams (LON:ZTF) and Essentra (LON:ESNT) are both small-cap basic materials companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, community ranking, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership. Is ZTF or ESNT a better dividend stock? Zotefoams pays an annual dividend of GBX 7 per share and has a dividend yield of 2.0%. Essentra pays an annual dividend of GBX 4 per share and has a dividend yield of 2.7%. Zotefoams pays out 3,500.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Is ZTF or ESNT more profitable? Zotefoams has a net margin of 7.45% compared to Essentra's net margin of -0.07%. Zotefoams' return on equity of 8.52% beat Essentra's return on equity.Company Net Margins Return on Equity Return on Assets Zotefoams7.45% 8.52% 5.48% Essentra -0.07%0.22%1.74% Do insiders & institutionals believe in ZTF or ESNT? 71.7% of Zotefoams shares are held by institutional investors. Comparatively, 121.7% of Essentra shares are held by institutional investors. 19.0% of Zotefoams shares are held by insiders. Comparatively, 1.0% of Essentra shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor ZTF or ESNT? Essentra received 116 more outperform votes than Zotefoams when rated by MarketBeat users. Likewise, 72.84% of users gave Essentra an outperform vote while only 69.49% of users gave Zotefoams an outperform vote. CompanyUnderperformOutperformZotefoamsOutperform Votes24669.49% Underperform Votes10830.51% EssentraOutperform Votes36272.84% Underperform Votes13527.16% Which has preferable earnings and valuation, ZTF or ESNT? Zotefoams has higher earnings, but lower revenue than Essentra. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZotefoams£133.40M1.29£9.93M£0.201,765.00Essentra£309.70M1.37£5.80MN/AN/A Does the media favor ZTF or ESNT? In the previous week, Essentra had 1 more articles in the media than Zotefoams. MarketBeat recorded 1 mentions for Essentra and 0 mentions for Zotefoams. Zotefoams' average media sentiment score of 0.00 equaled Essentra'saverage media sentiment score. Company Overall Sentiment Zotefoams Neutral Essentra Neutral Do analysts rate ZTF or ESNT? Essentra has a consensus target price of GBX 216.67, suggesting a potential upside of 46.79%. Given Essentra's stronger consensus rating and higher probable upside, analysts plainly believe Essentra is more favorable than Zotefoams.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zotefoams 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Essentra 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, ZTF or ESNT? Zotefoams has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Essentra has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. SummaryEssentra beats Zotefoams on 12 of the 18 factors compared between the two stocks. Ad Weiss RatingsRadical change could be coming — do this NOW to protect yourselfLegendary financial forecaster, Dr. Martin Weiss has recently uncovered what could be the Deep State's chilling plan to radically change America forever. It involves the Fed … Artificial Intelligence … And a Draconian set of laws that could install total financial surveillance …Click here to learn more. Get Zotefoams News Delivered to You Automatically Sign up to receive the latest news and ratings for ZTF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZTF vs. The Competition Export to ExcelMetricZotefoamsSpecialty Chemicals IndustryMaterials SectorLON ExchangeMarket Cap£171.56M£8.49B£2.92B£1.70BDividend Yield1.73%3.47%5.08%11.29%P/E Ratio1,765.00302.38112.501,738.01Price / Sales1.29475.65719,054.90316,277.21Price / Cash18.8719.4424.3026.55Price / Book1.435.253.493.05Net Income£9.93M£144.05M£150.42M£143.89M7 Day Performance-1.40%1.39%0.81%7.23%1 Month Performance-3.29%-3.28%-1.73%0.16%1 Year Performance10.31%-10.53%24.86%26.01% Zotefoams Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZTFZotefoamsN/AGBX 353+0.9%N/A+10.0%£171.56M£133.40M1,765.00549ESNTEssentra1.9772 of 5 starsGBX 144-0.6%GBX 216.67+50.5%-0.8%£413.48M£309.70M7,980.00350News CoverageSCPAScapa GroupN/AGBX 214.50flatN/A+0.0%£402.98M£281.80M-7.321,461SYNTSynthomerN/AGBX 167flatGBX 288.33+72.7%-6.8%£273.16M£1.97B-273.774,200TETTreatt2.3489 of 5 starsGBX 402flatGBX 700+74.1%+8.6%£244.09M£143.55M2,233.33350Dividend IncreaseAnalyst ForecastNews CoverageIOFIofina2.7654 of 5 starsGBX 18.50-2.6%GBX 35+89.2%-20.2%£35.49M£51.71M1,900.0095News CoverageGap DownWCHWilmcote Holdings plc (WCH.L)N/AGBX 3flatN/AN/A£20.13MN/A-5.003ITXItaconixN/AGBX 129.90+3.9%N/A-4.5%£17.52M£6.62M-3,247.5017Gap UpDCTADirecta PlusN/AGBX 8-6.2%N/A-70.0%£8.35M£9.33M-142.08187HDDHardideN/AGBX 5-3.8%N/A-53.5%£3.93M£4.73M-166.7346BIOMBiome TechnologiesN/AGBX 5.11+2.3%N/A-95.9%£2.64M£5.75M-15.4427 Related Companies and Tools Related Companies ESNT Alternatives SCPA Alternatives SYNT Alternatives TET Alternatives IOF Alternatives WCH Alternatives ITX Alternatives DCTA Alternatives HDD Alternatives BIOM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:ZTF) was last updated on 12/8/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredUrgent warning about your moneyThe stock market is booming … And Bitcoin just hiked through the roof. But don't get fooled by the "good...Weiss Ratings | SponsoredElon declares war on company he co-founded!?Elon Musk is leading humanity into the new era of AI. He’s just received a fresh $6 billion in funding for ...Porter & Company | SponsoredWall Street genius says this bubble has run its course – what to doWhile the media is telling you to be excited about the stock market, Wall Street and the market's top experts ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zotefoams plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zotefoams With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.